Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Krystal Biotech Stock (NASDAQ: KRYS) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 6.00 / 358.55K |
Day Range | - - - |
52 Wk Range | 93.95 - 219.34 |
Market Cap | $5.26B |
P/E Ratio | 46.63 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 43 |
Short Interest | 17.08% |
Days to Cover | 21.83 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Krystal Biotech (NASDAQ:KRYS) through any online brokerage.
Other companies in Krystal Biotech’s space includes: Immunovant (NASDAQ:IMVT), Avidity Biosciences (NASDAQ:RNA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Ionis Pharmaceuticals (NASDAQ:IONS) and Roivant Sciences (NASDAQ:ROIV).
Krystal Biotech has a consensus price target of $182.09.
The stock price for Krystal Biotech (NASDAQ: KRYS) is $184.17 last updated September 20, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Krystal Biotech.
Krystal Biotech’s Q3 earnings are confirmed for Monday, November 4, 2024.
There is no upcoming split for Krystal Biotech.
Krystal Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.